It is known that reactive oxygen (ROS) and nitrogen (RNS) species play a diverse role in various biological processes, such as inflammation, signal transduction, and neurodegenerative injury, apart from causing various diseases caused by oxidative and nitrosative stresses, respectively, by ROS and RNS. Thus, it is very important to quantify the concentration level of ROS and RNS in live cells, tissues, and organisms. Various smallmolecule-based fluorescent/chemodosimetric probes are reported to quantify and map the effective distribution of ROS/RNS under in vitro/in vivo conditions with a great spatial and temporal resolution. Such reagents are now appreciated as an excellent tool for aiding breakthroughs in modern redox biology. This minireview is a brief, but all-inclusive, account of such molecular probes that have been developed recently.
■ INTRODUCTION
In recent years, the efficacies of clinical diagnostics, therapeutics, and medicines have emerged due to our better insights and recent advances in the understanding of various biological processes at the cellular and molecular levels. 1 The biology of reactive oxygen and nitrogen species (ROS and RNS, respectively) is linked to the involvement of these intracellular molecular entities in various biological processes. 1−3 Endogenous ROS and RNS are formed through various intracellular biochemical processes, including nicotinamide adenine dinucleotide phosphate oxidase and mitochondrial electron transport chain. 4, 5 Exogenous sources (e.g., radiation, air pollutants, and certain redox-active xenobiotics) also cause an elevated level of ROS/RNS in living organisms. 6 ROS/RNS participate in biological processes as immunotoxins as well as immunomodulators, and their effective build-up in a living organism is linked to its generation as the byproducts of aerobic metabolism and the immune system processes. 7 Accumulation of the higher than the optimal level of ROS overhauls the antioxidant mechanisms and attributes to oxidative cellular stress. 8 Mechanisms or the biochemical processes which control the production of intracellular ROS/RNS are not well comprehended, and it is pertinent to develop diagnostic strategies at cellular sites of dysfunction. 9 Among various ROS and RNS that are operational in living organisms, we shall limit our discussions on the strategies for clinical diagnosis of hypochlorous acid (HOCl) as ROS and nitroxyl (HNO) as the RNS for this mini-review. The biochemistry of HOCl helps the neutrophils to kill a wide range of infectious agents. 10 It is produced during an oxidation reaction between the H 2 O 2 and Cl − ions which is catalyzed by the myeloperoxidase (MPO) enzyme, excreted by neutrophils in its inflammatory state. 10 Even though it plays a defensive role in human health, the elevated levels of HOCl are known to cause tissue damage and several diseases such as obesity, diabetes, atherosclerosis, lung injury, rheumatoid, cardiovascular diseases, neurodegenerative conditions, and various cancers. 10, 11 The chemistry of HNO (nitroxyl) and its conjugated base NO − is rather less explored as compared to HOCl. HNO is the protonated one-electron reduction product of NO and is isoelectronic with an oxygen molecule (O 2 ). Unlike HOCl, the knowledge base for insight into the role of HNO in human physiology is still in its infancy. Angeli's salt is the most commonly used chemical for the in situ generations of HNO (rate constant of 4.6 × 10 −4 s −1 (at room temperature)), and this process is favored over a pH range of 4−8. 12, 13 Commercial availability of this salt has helped in developing the mechanistic insights of reactions involving HNO with a particular emphasis on elucidation of the biochemical/physiological role. The linear HNO structure is less stable than the bent form by ca. 67 kcal/mol. Computational studies predicted the possible presence of a triplet state having energy of 18.0−19.0 kcal over the ground singlet state. 14, 15 However, to date, experimental evidence for 3 HNO is missing. Importantly, for NO − the triplet state (ground state) is more stable than the singlet state by ca. 16 kcal/mol. 16 Thus, the deprotonation process is associated with a change in spin state and is spin forbidden (adiabatic singlet−triplet transition energy is 18.45 kcal/mol), 17 and its generation is a slow process, which is attributed to HNO as the prevalent species (pK a HNO = 11.4) 18 at physiological pH. HNO is associated with numerous biological activities with significant therapeutic potential. A series of reports reveal that the alcohol-deterrent drug cyanamide (NH 2 CN) is really a prodrug for HNO, an inhibitor of the aldehyde dehydrogenase enzyme. 19 HNO has unique positive lusitropic and ionotropic effects in heart failure without a chronotropic effect and shows favorable effects in ischemia-reperfusion injury. Recent studies also reveal the role of HNO in cancer therapy.
Considering such significances, reagents for efficient recognition, quantification, and mapping of intracellular HOCl and HNO-inappropriate organelles or quantification in suitable biofluids are highly desired. This has attracted much attention among the researchers who are active in the area of chemical biology, environmental science, and clinical diagnostics. In recent years, a number of reports on fluorogenic receptors describing specific detection of these two analytes have appeared. In this short account, we shall limit our discussion only to the recently reported chemodosimetric receptors for HOCl and HNO. There is a recent account published by Wu, Chen, Yoon, and their co-workers on receptors that are specific toward HOCl. Those examples shall be avoided in this mini-review to avoid any repetition.
■ RESULTS AND DISCUSSION
Receptors for HOCl. HOCl is an efficient antimicrobial ROS with high oxidizing potential and is commonly produced in higher eukaryotes. HOCl oxidizes amino acids containing amines and sulfurs; in particular, methionine residues are oxidized to the corresponding methionine sulfoxide. The conversion of methionine sulfoxide is an efficient one with reaction rate approaching the diffusion limit. Recent studies reveal that a HOCl-specific transcription factor (HypT) contributes to HOCl resistance by upregulating the biochemical synthesis of three methionine residues (Met123, Met206, and Met230). This oxidizing efficiency of HOCl is being largely utilized for developing various chemodosimetric molecular probes.
Yang and his team reported an aqueous-soluble p-methoxyphenol derivative (1) as the dual-signaling (colorimetric and fluorimetric) chemodosimetric probe for HOCl in aqueous PBS buffer (pH 7.4) medium (Figure 1 ). 20 Following oxidation of 1 to the corresponding quinonoid derivative, a distinct change in the absorption maxima from 314 to 393 nm was observed with an associated reduction in the emission quantum yield at 388 nm. Other ROS and RNS species (
• NO, ONOO − , and ROO • ) failed to induce, and detectable changes in the optical spectrum for 1 and these data ensured specificity of this reagent toward HOCl. This was one of the initial reports on HOCl recognition. Presumably, the luminescence quenching process was the deterrent factor for the authors for exploring the option of using this reagent for intracellular studies.
Chen et al. reported the iridium(III) complex (2) having an oximated 2,2′-bipyridine for detection of ClO − . 21 A facile CN−OH isomerization was attributed to an efficient nonradiative decay process and the poor emission quantum yield ( Figure 2 ). Selective oxidation of the oxime to an aldehyde or carboxylic acid, induced by ClO − , caused a luminescence ON response having a luminescence maximum at 578 nm (λ ex = 346 nm) in DMF:aq. HEPES buffer medium (pH 7.2). An oxidized carboxy derivative showed a bright orange-yellow luminescence coming from from [5d(Ir) → π*(bpy)] 3 MLCT and [π(ppy) → π*(bpy)] 3 LLCT triplet excited states. The authors ensured the specificity of the reagent 2 toward ClO − in the presence of other common ROS species. Moreover, the use of test strips comprising 2 showed very promising sensitivity to ClO − . Similar oxime based probes 3 and 4 were also reported for specific detection of ClO − . 22, 23 A similar methodology was utilized for developing a rhodamine-based luminophore (5) , and this was further explored for mapping of the endogenous HOCl in live HeLa cells ( Figure 3 ). 24 Loo, Zhang, and co-workers reported a hybrid upconversion luminescence (UCL) detection system (6) for HOCl ( Figure 4 ). 25 Upconverting luminescence nanoparticles (UCNP) are generally preferred over conventional luminescent molecular probes owing to their stability toward photobleaching, deeper tissue penetration of the near-infrared (NIR) active radiation, minimal or no selfinduced fluorescence, and less tissue damage. 26−28 The extent of loading of the rhodamine-based oxidizable receptor was calculated as ∼5.81 wt %. The amino-terminated rhodamine derivative was loaded onto the surface of UCNPs via interactions with oleic acid (OA) termini. Polyacrylic acid (PAA) was further used to replace OA ligands from the surface of UCNPs, which not only helped in creating an aqueous-soluble triple-layer nanostructure but also prevented the rhodamine derivative from detachment from the UCNP surface. Upon reaction of 6 with HOCl, there was a gradual decrease in green emission from UCL with concomitant increase in the rhodamine-based emission due to the conversion of the cyclic lactam from an acyclic xanthene form through an efficient FRET-based energy transfer process. This ratiometric response was successfully utilized for mapping intracellular HOCl that was released by MPO-mediated peroxidation of chloride ions in living cells. A similar probe 7 was further reported by Xu et al. for specific detection of HOCl. 29 Figure 4 . (a) Schematic representation of the hybrid UCNP-based recognition of HOCl and the molecular structures for 6 and 7. (b) Ratiometric UCL images of NIH3T3 cells: the cells preincubated with hybrid-UCNPs in the MPO enzymatic system (MPO enzyme, 2.0 U/100 mL; NaCl, 250 mM) for 30 min at 37°C and then further incubated with 100 μM H 2 O 2 for 180 min (i−iv). Emissions were collected by the green UCL window at λ 500−560 nm (i and v) and red UCL window at λ 600−700 nm (iii and vii) with excitation at 980 nm. Overlay of bright-field and green channel UCL images shown in the panel (ii and vi). The ratiometric UCL intensities of NIH3T3 cells (iv and viii) were examined by using IPP software. The sulfur-containing rhodamine derivatives showed greater selectivities for OCl − than those of Se and Te. In 2007, Nagano and co-workers presumably were the first to demonstrate this using an appropriate S-functionalized rhodamine derivative (8) . 30 Authors have also demonstrated the use of this reagent for mapping the hypochlorous acid that was created inside phagosomes in real time ( Figure 5 ).
The authors have reported a formylhydrazine derivative of rhodamine B (9) for specific recognition of intracellular HOCl in live RAW 264.7 macrophage cells ( Figure 6 ). 31 A single conjugated flexible polymer having reactive centers for HOCl and target-inert fluorophores was designed. This farred to NIR nanoprobe (10) helped in identifying intracellular HOCl through a FRET-based ratiometric detection ( Figure 7 ). 32 Reagent 10 was successfully used for mapping of HOCl fluctuations in macrophage cells. The dual-emission property of 10 enabled a more sensitive mapping of ClO − in peritonitis in mice with high contrast.
The azo functionality having an o-amino group substituted in a phenyl ring undergoes selective oxidation with HOCl to produce a triazole functionality. This was utilized in developing Ru(II)-polypyridyl-based luminescent sensors (11 and 12) for HOCl ( Figure 8 ). 33 BODIPY derivative (13, Figure 9 ) was used successfully for mapping endogenously produced HOCl in RAW 264.7 macrophages. 34 Wide-field and super-resolution structured illumination microscopy (SR-SIM) images confirmed localization of the reagent in the Golgi complex and lysosomes. Importantly, reagent 13 was found to be suitable with 3D-SIM imaging of a single cell.
Two-Photon Reagents for HOCl Recognition. Presumably, the first two-photon (TP) active reagent for HOCl was reported by Chang and co-workers. 35 The first TP-active reagents (14 and 15) that were specific for imaging HOCl in the mitochondria (14) and lysosome (15) are shown in Figure 10 . 35 These probes showed good selectivity toward HOCl. In particular, the TP imaging of 14 and 15 in the murine model revealed that the elevated amount of HOCl could be identified in both the mitochondria and lysosome of macrophage cells under inflammation conditions. Thus, these reagents could be utilized to understand the roles of HOCl at subcellular levels.
A new TP fluorescent probe (16) having a pendant imidazoline-2-thione as an OCl − identification unit and triphenylphosphine as a mitochondrial-targeting group were reported. 36 The precise reaction among imidazoline-2-thione and OCl − ̅ accounted for the luminescence ON response and the basis for specific recognition even in the presence of other ROS species. This TP-active reagent 16 was utilized to image endogenously created mitochondrial OCl − in live HeLa, HepG2, and RAW 264.7 cells via TP microscopy ( Figure 11 ). Despite being TP-active, this reagent was not utilized for tissue imaging.
The two-photon activity of the naphathalimide derivative was utilized for developing a lysosome-specific luminescent molecular probe (17) that had morpholine functionality as the lysosome-targeting group. 37 Reagent 17 was oxidized to the corresponding sulfoxide species by ClO − with an associated luminescence OFF response. Unlike other examples, this reaction triggered an OFF response, which could be revived by GSH.
The naphthoimidazolium borane derivative (18) participated in an electrophilic oxidation mechanism associated with B−H bond degradation to yield a TP-active naphthoimidazolium derivative. 38 This reagent could be utilized for monitoring of endogenously produced HOCl and the changes in endoplasmic reticulum during oxidative stress situations. Endogenous OCl − mapping in macrophages was then studied. Macrophages were stimulated by lipopolysaccharides (LPS) and interferon γ (IFN-γ). MPO was attributed to an in situ generation of OCl − and was further treated with phorbol myristate acetate (PMA). These studies confirmed the efficacy of the reagent for recognition of intracellular OCl − through TP microscopy (Figure 12 ).
Guo and co-workers have reported a series of reagents for intracellular quantification of HOCl by introducing a bioorthogonal dimethylthiocarbamate receptor (Figure 13 ). 39 The authors have successfully demonstrated the role of the S atom in designing this set of molecular probes (Figure 13 a) . Among these, reagent 19 is found to be the most efficient one, while allowing a ratiometric luminescence response on a specific reaction with HOCl at high risk pathogenic concentrations (0.47 mM). This reagent showed 48-fold enhancement in the ratio for I 468 nm /I 630 nm with a good linear relationship. The release of the thiocarbamate moiety of 19 on reaction with HOCl led to the generation of the corresponding phenol derivative having a luminescence maximum of 468 nm. The formation of the phenolic derivative induced an excited-state intramolecular proton transfer and intramolecular charge transfer processes to result in a 468 nm luminescence. The authors could demonstrate the use of this reagent for monitoring the oxidative stress process induced by elesclomol in live cancer cells (Figure 13b ).
■ VARIOUS RECEPTORS FOR HNO
Initially it was perceived that HNO chemical biology was similar to NO as a biological conciliator. Unfavorable redox potential does not allow a facile reduction of NO to HNO in physiological conditions. However, moderate H−NO bond strength (50 kcal mol −1 ) makes HNO a more efficient hydrogen atom donor than many other biological antioxidants. This may potentially react with the appropriate ROS/RNS-based radical species to generate NO, which subsequently reacts, oxidizing radical species to quench. 40 There is a recent short account on receptors that are specific toward HNO published by Lin and co-workers. We shall be avowing any appreciable overlap with examples that are discussed in this mini-review.
Thus, the reactivity and biological implications of HNO and NO are not similar; it is worth knowing some of the early reports by Lippard and co-workers in NO recognition. These results have certainly helped researchers in understanding the clinical biology of HNO and are mentioned briefly before discussing some of the recent efforts on HNO recognition.
Lippard's group reported a series of Cu(II) complexes for the detection of NO and were almost silent toward HNO. One of the representative Cu(II) complexes (20) is shown in Figure 14 . These probes were successfully imaged NO in HeLa cells and RAW 264.7 macrophages. 41 Luminescence response of 20 toward NO was specific. Experimental studies revealed that the NO-triggered fluorescence enhancement for 19 happened through generation of Cu(I) with subsequent dissociation to a luminescent secondary amine N−NO derivative.
To explicate the factors that impart the selectivity for nitroxyl (HNO) over nitric oxide (NO) among the metal-based fluorescent reagents, Lippard and co-workers had studied a series of Cu(II)-cyclam derivatives, and the one (21) that showed most positive reduction potential of the series promoted reduction of Cu(II) (Figure 15 ). 42 Generation of Cu(I) with necessary structural changes to adjust and stabilize the tetrahedral Cu(I) center was stated to be crucial and attributed to a luminescence ON response. It is worth mentioning that reduction of the nitrosonium cation (NO + ) to NO occurs at 1.52 V (vs NHE) and fails to reduce Cu(II) in 21. This is attributed to the specificity toward HNO over NO. Lippard and co-workers have developed another Cu(II) complex (22) of the mixed thia/aza 14-N 2 S 2 ligand, which was found to react reversibly with HNO at pH 7. 43 Nakagawa et al. introduced a rhodamine-based HNO specific probe 23 utilizing diphenylphosphine as a response site. HNO reacted with the probe to yield a luminescent rhodamine derivative ( Figure 16 ). 44 An analogous methodology was utilized by Lin et al. for developing reagents (24−26) that were sensitive to HNO and showed turn ON luminescence response. 45 Diphenylphosphine as a responsive site was exploited for designing these receptors. The reagents could show various emission colors from green to NIR in response to HNO in aqueous solution and inside the cells (Figure 17) . For the first time, by incubating the living cells with these reagents simultaneously, we demonstrate the multicolor imaging of HNO with emission colors in the range of green to NIR in living systems. Furthermore, reagent 27 showed large turn-on NIR fluorescence signal upon excitation in the NIR region. This reagent was also used successfully for detection of HNO in living mice. The same research group has exploited a similar approach for developing another rhodamine derivative for recognition of intracellular HNO. 46 A similar reaction was utilized by Das and co-workers for developing another reagent 28. 47 This reagent showed high specificity toward HNO and localization at the endoplasmic reticulum of RAW 264.7 cells. This photophysical property of this reagent was found to be well-suited for its use in SR-SIM and two-color SIM imaging, permitting more than one organelle to be imaged at SR-SIM ( Figure 18 ). The option of using this probe for in vivo imaging application was exhibited using a small marine invertebrate model, Artemia. Designed substitution at the pyrrole ring with extended conjugation helped in achieving a luminescence response with maximum at longer wavelength (586 nm). The analogous methodology was adopted for developing another new BODIPY derivative (29) for specific recognition of HNO. 48 The hydrophobic interior of an amphiphilic copolymer (mPEG-DSPE; DSPE: 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy(polyethylene glycol)-2000) was utilized for encapsulating the reagent 29 to prepare a micellar nanoprobe. This reagent showed a ratiometric luminescence response on specific reaction with HNO. Reagent 29 showed efficient cellular internalization and was effectively used to detect HNO in living HepG2 cells, as well as in zebrafish larvae ( Figure 19) .
As discussed earlier, the reactivity of HNO with biological thiols reaches the diffusion control limit with rate constants ∼10 9 M −1 s −1 . To address this, Chan and co-workers had reported a new thiol-based reagent (30) that had the potential to compete against reactive thiols for HNO. 49 The molecular structure and the luminescent reaction product are shown in Figure 20 . Treatment of 30 with an HNO donor resulted in a 16-fold enhancement in luminescence intensity. Authors have argued that this reagent showed improved specificity over various ROS/RNS species and efficacy in the presence of biothiols (e.g., glutathione in mM concentrations).
■ CONCLUSIONS
Significant advances are achieved in designing appropriate receptors for HOCl and HNO, and some of the initial and most recent examples are summarized in this short account. However, more concerted efforts are still needed to design the probe for efficient application in clinical biology and therapeutics. To date, there are only a few examples that are either NIR-active or TP-active. Such reagents open up the possibility of developing more efficient reagents. It is argued that one of the unanswered questions in the field of HNO pharmacology/physiology remains: is HNO endogenously generated as a physiological effector/mediator? A question which could, perhaps, be addressed by developing a reagent that tracks/maps the HNO generated through endogenous biosynthesis during cardiovascular stress. Researchers have not addressed the query: how can HNO discriminate between thiol proteins? Addressing such unanswered questions would help in developing an insight into understanding the proper physiological function for HNO which in turn would help us in designing appropriate and efficient receptors for HNO. The chemistry of HOCl is a little better understood. Still, there are many unanswered questions for the physiological role of HOCl, and the area of clinical diagnosis of endogenous HOCl still needs attention. Better insight into the HOCl defense mechanism at the molecular level and effective real-time quantification of endogenous HOCl would help not only in controlling many pathogenic bacteria by counteracting them but also for developing efficient molecular probes for HOCl. 
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